Major Milestone For Diurnal As FDA Approves Alkindi

Partner Eton Predicts $100m Sales For Adrenal Insufficiency Drug

 
• By Kevin Grogan
  
Independence day
Diurnal celebrating after US approval of Alkindi • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip